Market intelligence, trend analysis and forecasts for the Pharma and Healthcare industries across the regions

Japan

Japan Articles

Industry

Through their involvement in this growing trend, Shionogi, Daiichi Sankyo, Astellas Pharma, Takeda and Eisai can expect to reap huge reputational benefits, as well as access to knowledge... 2013-04-26


Industry

Emerging markets will drive industry growth. The importance of emerging markets to large multinational drugmakers cannot be overstated. BMI's Pharmaceutical Expenditure Model reveals... 2013-04-24


Industry

A prescription medicine that treats a 'lifestyle' disease has been launched for the first time as an over-the-counter (OTC) drug in Japan. This is significant given that previous such... 2013-04-18


More ARTICLES

Industry

BMI View: We believe drugmakers based in emerging markets will expand their presence in developed countries. Although firms in developing countries enjoy low operating costs, they have... 2013-03-14


Industry

BMI View: Japan's renewed interest in stem cell research will help the country maintain its position alongside South Korea as a pre-eminent innovator in biomedical sciences in Asia.... 2013-03-05


Industry

BMI View: Shockwaves from the biennial drug price cut continue to impact pharmaceutical firms in Japan. We highlight that domestic pharmaceutical companies are affected more than overseas... 2013-02-28


Industry

BMI Core View: Uptake of generic drugs in the wake of patent expirations will become swifter. This trend will reduce costs for governments, out-of-pocket payers and insurance companies,... 2013-01-11


Industry

BMI View: Considering Japan's lacklustre economic trajectory and recently unsettled political environment, as well as its extremely challenging demographic profile, the country's healthcare... 2012-07-09